GlassScriptPhysician profile
Aaron W Terry
NPI 1497944631
$799.44
in general payments reported to CMS, 2019-2025
15 companies · $13.63 in 2025
The $13.63 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $72.96 · 2020: $290 · 2021: $237 · 2022: $99.06 · 2023: $66.00 · 2024: $20.68 · 2025: $13.63.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $100.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $100.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $216.20 | 2020-2021 | |
| Abbvie INC. | $192.49 | 2020-2025 | |
| Intuitive Surgical, INC. | $94.30 | 2022-2023 | Da Vinci Surgical System |
| Astellas Pharma US INC | $58.01 | 2019 | |
| Eisai INC. | $46.44 | 2020 | |
| Abbott Laboratories | $37.76 | 2021-2023 | Proclaim |
| Lilly USA, LLC | $24.86 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $21.35 | 2021 | |
| Glaxosmithkline, LLC. | $20.68 | 2024 | Shingrix, Arexvy |
| Supernus Pharmaceuticals, INC. | $15.11 | 2021 | |
| Horizon Therapeutics Plc | $14.95 | 2019 | |
| Acclarent, INC | $14.80 | 2021 | |
| Merck Sharp & Dohme LLC | $14.61 | 2020 | |
| Boston Scientific Corporation | $14.25 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $13.63 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron Terry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.